Journal article
Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1
The Journal of immunology (1950), Vol.183(5), pp.2966-2973
09/01/2009
DOI: 10.4049/jimmunol.0900442
PMCID: PMC2747101
PMID: 19667091
Abstract
The EBV protein, latent membrane protein 1 (LMP1), is a functional mimic of the cellular receptor CD40, but signals to B lymphocytes in an amplified and sustained manner compared with CD40. LMP1 contributes to the development of B cell lymphoma in immunosuppressed patients, and may exacerbate flares of certain autoimmune diseases. The cytoplasmic domain of LMP1 binds the signaling adaptor TRAF2 with lower avidity than the cytoplasmic domain of CD40, and TRAF2 is needed for CD40-mediated degradation of TRAFs 2 and 3. LMP1 doesn't induce TRAF degradation, and employs TRAF3 as a positive mediator of cell signaling, whereas CD40 signals are inhibited by TRAF3. We thus tested the hypothesis that relative affinity for TRAF2, and/or distinct sequence differences in the TRAF2/3 binding sites of CD40 vs LMP1, controls the disparate ways in which CD40 and LMP1 use TRAFs 2 and 3, and their distinct signaling characteristics. CD40 and LMP1 mutants in which the TRAF binding site sequences were swapped were examined, testing TRAF binding and degradation, and induction of B cell activation. Results revealed that TRAF binding affinity and TRAF binding site sequence dictate a distinct subset of CD40 vs LMP1 signaling properties. Examination of TRAF binding, degradation, cytokine production, IgM secretion, and the activation of c-Jun kinase and NF-kappaB revealed that some events are dictated by TRAF binding site sequences, others are partially regulated, and still others are independent of the TRAF binding site sequence.
Details
- Title: Subtitle
- Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1
- Creators
- John P Graham - Interdisciplinary Program in Immunology, Veterans Affairs Medical Center, Iowa City, Iowa 52242, USACarissa R MooreGail A Bishop
- Resource Type
- Journal article
- Publication Details
- The Journal of immunology (1950), Vol.183(5), pp.2966-2973
- DOI
- 10.4049/jimmunol.0900442
- PMID
- 19667091
- PMCID
- PMC2747101
- NLM abbreviation
- J Immunol
- ISSN
- 0022-1767
- eISSN
- 1550-6606
- Publisher
- United States
- Grant note
- T32 AI007485-12 / NIAID NIH HHS R01 AI049993-07 / NIAID NIH HHS R01 CA099997-02 / NCI NIH HHS R01 AI049993 / NIAID NIH HHS T32 HL007638 / NHLBI NIH HHS T32 AI007485-13 / NIAID NIH HHS T32 HL07638-18 / NHLBI NIH HHS R56 AI049993 / NIAID NIH HHS R01 CA099997-03 / NCI NIH HHS R01 CA099997-05 / NCI NIH HHS T32 AI007485-14 / NIAID NIH HHS AI49993 / NIAID NIH HHS R01 AI049993-09 / NIAID NIH HHS R01 AI049993-05 / NIAID NIH HHS R01 CA099997-01 / NCI NIH HHS T32 AI007485 / NIAID NIH HHS R01 AI049993-08 / NIAID NIH HHS T32 AI007485-15 / NIAID NIH HHS CA099997 / NCI NIH HHS R01 AI049993-06 / NIAID NIH HHS R01 CA099997-04 / NCI NIH HHS R01 CA099997 / NCI NIH HHS T32 AI007485-11 / NIAID NIH HHS
- Language
- English
- Date published
- 09/01/2009
- Academic Unit
- Microbiology and Immunology; President
- Record Identifier
- 9984002397202771
Metrics
21 Record Views